Sartorius Stedim Biotech SA: Half-year liquidity contract statement for Sartorius Stedim Biotech
Sartorius Stedim Biotech SA
Sartorius Stedim Biotech SA: Half-year liquidity contract statement for Sartorius Stedim Biotech
05-Jul-2022 / 14:03 CET/CEST
Dissemination of a French Regulatory News, transmitted by EQS Group.
The issuer is solely responsible for the content of this announcement.
Aubagne, July 1, 2022
Half-year liquidity contract statement for Sartorius Stedim Biotech
Under the liquidity contract entered into between Sartorius Stedim Biotech and Kepler Cheuvreux, the following resources appeared on the liquidity account on June 30th 2022:
20,241 shares € 3,286,293.04 Number of executions on buy side on semester: 4,639 Number of executions on sell side on semester: 4,205 Traded volume on buy side on semester: 186,508 shares for € 64,215,074.25 Traded volume on sell side on semester: 169,628 shares for € 57,532,559.42
As a reminder, the following resources appeared on the last half year statement on 31 December 2021 on the liquidity account:
3,361 shares € 9,978,179.44 Number of executions on buy side on semester: 2,810 Number of executions on sell side on semester: 2,600 Traded volume on buy side on semester: 95,701 shares for € 44,247,756.63 Traded volume on sell side on semester: 94,714 shares for € 45,073,166.52
The following resources appeared on the liquidity account when the activity started:
0 shares € 10,000,000.00
The implementation of this report is carried out in accordance with AMF Decision N°2021-01 of June 22nd 2021 renewing the implementation of liquidity contracts for shares as an accepted market practice.
A profile of Sartorius Stedim Biotech
Sartorius Stedim Biotech is a leading international partner of the biopharmaceutical industry. As a total solutions provider, the company helps its customers to manufacture biotech medications safely, rapidly and economically. Headquartered in Aubagne, France, Sartorius Stedim Biotech is quoted on the Eurolist of Euronext Paris. With its own manufacturing and R&D sites in Europe, North America and Asia and an international network of sales companies, Sartorius Stedim Biotech has a global reach. The Group has been annually growing by double digits on average and has been regularly expanding its portfolio by acquisitions of complementary technologies. In 2021, the company employed more than 10,400 people, and earned sales revenue of around 2.89 billion euros.
Contact
Petra Müller
Head of Investor Relations
+49 (0)551.308.6035
Petra.mueller2@sartorius.com
Sartorius Stedim Biotech S.A.
Z.I. Les Paluds
Avenue de Jouques, CS 91051
13781 Aubagne Cedex, France
Phone: +33.(0)4.42.84.56.00
Fax: +33.(0)4.42.84.56.19
www.sartorius.com
Buy side
Sell side
Number of executions
Number of shares
Traded volume in EUR
Number of executions
Number of shares
Traded volume in EUR
TOTAL
4,639
186,508
64,215,074.25
4,205
169,628
57,532,559.42
03/01/2022
17
700
335,202.00
7
300
146,901.00
04/01/2022
163
6,500
2,963,480.00
15
500
243,800.00
05/01/2022
86
2,100
912,702.00
3
100
43,900.00
06/01/2022
44
1,300
551,499.00
7
400
170,200.00
07/01/2022
18
500
209,800.00
5
200
84,800.00
10/01/2022
122
5,500
2,206,820.00
-
-
-
11/01/2022
23
900
361,530.00
49
2,900
1,185,404.00
12/01/2022
15
342
138,595.50
22
800
329,504.00
13/01/2022
112
3,958
1,563,726.64
-
-
-
14/01/2022
91
2,600
971,048.00
3
200
75,100.00
17/01/2022
45
900
326,403.00
41
1,500
557,775.00
18/01/2022
41
1,300
477,100.00
1
100
36,780.00
19/01/2022
25
800
293,592.00
68
2,201
821,083.05
20/01/2022
29
1,215
453,231.45
53
2,199
830,672.25
21/01/2022
54
1,785
673,498.35
37
1,300
493,103.00
24/01/2022
62
2,400
887,928.00
31
1,300
484,601.00
25/01/2022
46
2,000
720,260.00
28
700
256,928.00
26/01/2022
21
500
179,000.00
49
1,900
693,709.00
27/01/2022
63
1,884
669,856.20
49
2,032
736,315.52
28/01/2022
-
-
-
50
1,400
523,194.00
31/01/2022
1
100
38,000.00
61
900
346,806.00
01/02/2022
3
200
77,600.00
21
800
313,304.00
02/02/2022
-
-
-
18
600
238,500.00
03/02/2022
39
1,200
466,632.00
9
300
118,500.00
04/02/2022
-
-
-
16
900
351,027.00
07/02/2022
28
1,000
385,500.00
33
1,400
545,720.00
08/02/2022
125
5,100
1,908,318.00
19
1,009
395,195.03
09/02/2022
-
-
-
49
3,400
1,286,968.00
10/02/2022
50
3,405
1,267,953.90
27
900
339,147.00
11/02/2022
51
3,195
1,163,906.55
27
1,200
443,340.00
14/02/2022
78
2,316
814,838.28
4
200
71,100.00
15/02/2022
-
-
-
60
3,000
1,080,030.00
16/02/2022
33
1,700
605,472.00
-
-
-
17/02/2022
17
951
335,807.61
30
800
287,704.00
18/02/2022
61
2,297
785,459.15
-
-
-
21/02/2022
24
903
297,565.59
14
900
297,900.00
22/02/2022
42
1,000
321,400.00
21
1,000
327,450.00
23/02/2022
13
500
166,000.00
7
300
100,599.00
24/02/2022
69
1,815
584,411.85
21
1,800
595,008.00
25/02/2022
-
-
-
26
800
270,848.00
28/02/2022
15
500
167,400.00
44
1,600
553,344.00
01/03/2022
45
1,600
535,200.00
38
2,100
718,095.00
02/03/2022
32
800
271,352.00
8
400
139,500.00
03/03/2022
12
800
266,800.00
-
-
-
04/03/2022
43
1,600
515,120.00
1
100
33,700.00
07/03/2022
61
1,100
335,995.00
30
1,400
443,394.00
08/03/2022
35
1,300
397,696.00
-
-
-
09/03/2022
-
-
-
27
1,400
437,500.00
10/03/2022
-
-
-
16
600
193,500.00
11/03/2022
19
800
249,920.00
22
1,100
349,195.00
14/03/2022
10
400
125,400.00
49
2,500
806,250.00
Buy side
Sell side
Number of executions
Number of shares
Traded volume in EUR
Number of executions
Number of shares
Traded volume in EUR
TOTAL
4,639
186,508
64,215,074.25
4,205
169,628
57,532,559.42
15/03/2022
18
1,056
344,087.04
48
1,800
593,298.00
16/03/2022
-
-
-
61
2,400
822,192.00
17/03/2022
31
1,700
600,406.00
33
1,500
533,865.00
18/03/2022
23
1,200
423,000.00
42
2,000
717,540.00
21/03/2022
38
2,200
795,410.00
34
1,700
618,392.00
22/03/2022
34
1,346
480,293.18
27
1,400
504,406.00
23/03/2022
42
2,000
724,300.00
29
1,003
367,218.36
24/03/2022
31
1,500
529,905.00
16
900
320,499.00
25/03/2022
19
904
325,195.92
59
3,097
1,126,564.72
28/03/2022
22
1,100
394,295.00
55
2,100
763,392.00
29/03/2022
5
200
74,300.00
119
4,200
1,592,052.00
30/03/2022
44
2,000
768,500.00
31
1,200
464,304.00
31/03/2022
38
1,900
718,105.00
18
900
345,699.00
01/04/2022
17
700
260,001.00
36
1,600
601,904.00
04/04/2022
10
300
115,200.00
58
2,400
927,408.00
05/04/2022
9
600
234,702.00
51
1,900
748,087.00
06/04/2022
56
2,338
916,308.96
29
1,100
434,896.00
07/04/2022
34
1,700
665,108.00
44
1,900
746,909.00
08/04/2022
76
3,000
1,149,990.00
21
217
85,949.36
11/04/2022
72
3,100
1,131,531.00
11
600
223,398.00
12/04/2022
65
2,900
1,029,210.00
49
2,200
792,000.00
13/04/2022
38
2,100
741,426.00
24
1,200
428,400.00
14/04/2022
50
1,800
623,394.00
27
1,200
420,204.00
19/04/2022
43
1,700
567,103.00
36
1,600
536,848.00
20/04/2022
13
631
211,138.91
45
2,000
678,200.00
21/04/2022
58
2,600
909,506.00
121
3,400
1,201,900.00
22/04/2022
90
4,000
1,323,920.00
18
900
304,101.00
25/04/2022
72
2,300
716,634.00
58
1,800
566,100.00
26/04/2022
46
2,300
700,304.00
6
300
93,201.00
27/04/2022
64
2,500
741,300.00
54
2,300
689,448.00
28/04/2022
12
600
181,200.00
66
2,500
764,350.00
29/04/2022
15
900
280,197.00
43
1,500
471,180.00
02/05/2022
60
3,300
990,264.00
46
1,802
546,204.22
03/05/2022
34
1,400
422,996.00
47
1,698
517,805.10
04/05/2022
31
1,800
541,800.00
19
642
194,821.32
05/05/2022
36
1,900
575,263.00
61
2,100
648,501.00
06/05/2022
30
1,400
412,104.00
20
1,100
325,468.00
09/05/2022
35
1,600
464,896.00
24
1,200
351,204.00
10/05/2022
22
1,055
303,249.20
35
1,500
434,205.00
11/05/2022
29
1,500
432,795.00
54
2,200
640,816.00
12/05/2022
86
2,300
647,220.00
16
993
279,936.63
13/05/2022
1
23
6,647.00
86
2,900
844,016.00
16/05/2022
43
1,800
542,646.00
71
2,500
760,700.00
17/05/2022
22
1,200
362,604.00
37
1,200
364,644.00
18/05/2022
28
1,600
479,328.00
21
713
216,031.87
19/05/2022
54
1,300
381,004.00
44
2,287
679,810.75
20/05/2022
18
569
173,607.59
36
1,377
422,394.75
23/05/2022
37
2,000
620,200.00
51
1,900
593,959.00
24/05/2022
38
1,400
431,704.00
31
1,400
434,994.00
Buy side
Sell side
Number of executions
Number of shares
Traded volume in EUR
Number of executions
Number of shares
Traded volume in EUR
TOTAL
4,639
186,508
64,215,074.25
4,205
169,628
57,532,559.42
25/05/2022
38
1,698
519,859.68
33
1,301
401,345.49
26/05/2022
26
1,200
368,196.00
30
1,107
340,889.58
27/05/2022
-
-
-
62
2,092
657,766.64
30/05/2022
-
-
-
33
1,300
425,906.00
31/05/2022
51
1,900
617,215.00
29
1,100
361,295.00
01/06/2022
44
2,000
630,300.00
20
800
254,504.00
02/06/2022
19
900
281,799.00
58
2,300
725,098.00
03/06/2022
54
1,800
582,408.00
41
1,200
393,420.00
06/06/2022
20
1,022
327,734.96
36
1,400
450,730.00
07/06/2022
33
1,800
573,894.00
28
1,600
512,608.00
08/06/2022
18
800
256,704.00
34
1,308
421,712.28
09/06/2022
34
1,433
457,098.34
23
900
288,603.00
10/06/2022
63
2,267
714,105.00
30
1,200
382,692.00
13/06/2022
76
2,100
638,232.00
28
900
275,499.00
14/06/2022
44
2,000
600,900.00
49
1,300
399,594.00
15/06/2022
29
1,144
339,470.56
46
1,500
449,175.00
16/06/2022
62
2,056
602,305.20
8
400
117,900.00
17/06/2022
40
1,900
550,791.00
57
1,950
574,411.50
20/06/2022
44
2,000
565,900.00
21
1,200
345,024.00
21/06/2022
15
900
252,900.00
27
1,000
282,700.00
22/06/2022
19
1,000
272,300.00
29
1,600
443,408.00
23/06/2022
23
1,000
277,280.00
33
1,700
477,496.00
24/06/2022
1
100
28,500.00
52
1,800
532,008.00
27/06/2022
-
-
-
38
1,100
343,101.00
28/06/2022
27
1,500
459,405.00
15
700
216,398.00
29/06/2022
46
1,424
420,735.04
26
1,400
418,040.00
30/06/2022
41
1,476
433,722.60
35
1,700
504,424.00
File: Half-year liquidity contract statement for Sartorius Stedim Biotech
Language: English Company: Sartorius Stedim Biotech SA Avenue de Jouques 13781 Aubagne France Phone: +33 44 284 5600 E-mail: info@sartorius-stedim.com Internet: www.sartorius-stedim.com ISIN: FR0013154002 Euronext Ticker: DIM AMF Category: Share buyback / Disposal of own shares / Information relating to the liquidity contract EQS News ID: 1391143 End of Announcement EQS News Service
1391143 05-Jul-2022 CET/CEST